Bank of Greece (TELL)
Athens Exchange · Greece · prices in EUR · close of 22 Oct 2026
Key indicators
| Last close | EUR 14.80 |
|---|---|
| 52-week range | 14.40 – 17.50 |
| Return, 1 month / 3 months | −1.3% / +1.0% |
| Return, 1 year / 3 years | −0.7% / +13.9% |
| Trend | Below its 200-day average |
| RSI (14) | 46 |
| Volatility (1 year) | 14.7% |
| Worst drawdown (1 year) | -15.4% |
| Average daily value traded | 0.11M EUR |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
The Bank of Greece is the central bank of Greece, based in Athens. It carries out central banking functions for the country, including implementing the monetary policy of the euro area, supervising banks and other credit institutions, and overseeing payment systems. It manages the country's foreign reserves, produces and distributes banknotes and coins, and collects economic statistics. Its counterparties are financial institutions and the state, and it works alongside other national central banks within the European System of Central Banks.
Bank of Greece trades under the code TELL on the Athens Exchange in Greece, with its price quoted in euros (EUR). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Bank of Greece (TELL) trades on the Athens Exchange in Greece. It last closed at EUR 14.80 on 22 October 2026.
Its price-based Market X-Ray is 63 out of 100 (a fair price profile), ranking 40 of 143 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 0.7% and over the last three months it rose 1.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Athens Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 50 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -2.5% | ||
| From 52-week high | -14.2% | ||
| Momentum | 51 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 1.0% | ||
| 6-month return | -0.2% | ||
| 12-month return, skipping the last month | 0.7% | ||
| Stability (higher is calmer) | 91 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 14.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -15.4% | ||
| Liquidity | 61 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.11M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 2 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Trend: Below its long-term averages and far from its highs.
Returns
| 1 week | −1.0% |
|---|---|
| 1 month | −1.3% |
| 3 months | +1.0% |
| 6 months | −0.2% |
| 1 year | −0.7% |
| 3 years | +13.9% |
| 5 years | −1.4% |
Signals
| 50-day / 200-day average | 14.96 / 15.19 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.21 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 20 Apr 2023 | EUR 0.6720 |
| 5 May 2022 | EUR 0.6720 |
| 8 Apr 2021 | EUR 0.6720 |
| 26 Mar 2020 | EUR 0.6720 |
| 4 Apr 2019 | EUR 0.6720 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Athens Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.